We also validated these results at the protein level using multitarget immunofluorescence staining to label E-cadherin and vimentin in the patient tumor tissues and the paired para-carcinomous tissues with fluorescently labeled antibodies (Figures 2C, D). This evidence concerns the gene CDH1 and neoplasm.